VTRS - CIK 0001792044
Viatris Inc trades as VTRS and has a market capitalization of $18.36 B, making it the #647 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $14.25B, down 3.0% from the prior year and net income of $0.00. This page tracks Viatris Inc through 519 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 7 fiscal years Viatris Inc's revenue grew from $11.27B to $14.25B, a compound annual growth rate of 3.4%.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-05 |
| Major company event | 8-K | 2026-05-04 |
| SCHEDULE 13G | - | 2026-04-30 |
| Insider trade | 4 | 2026-04-16 |
| Annual report to shareholders | ARS | 2026-04-02 |
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain | Viatris
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference | Viatris
Viatris Reports First-Quarter 2026 Financial Results | Viatris
The page you are about to visit contains information about Viatris that is specific to Spain . Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.
Viatris Announces Chief Financial Officer Transition | Viatris
The largest companies sharing Viatris Inc's SEC industry classification (pharmaceutical preparations).
Viatris Inc (VTRS) has a market capitalization of $18.36 B as of 2026-06-10, ranking #647 among US-listed companies.
Viatris Inc reported revenue of $14.25B for fiscal year 2025, a decrease of 3.0% year over year.
Yes. Viatris Inc reported net income of $0.00 in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.